Data Insights
Artificial Intelligence (10)
Big Data (4)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (3)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Individualism & Expression (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Personalization (1)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (3)
Showing 2 results out of 2
How digitalization private equity performed in the pharmaceutical industry in Q1 2024
Analysis of the key themes driving private equity deal activity reveals that digitalization accounted for 3 pharmaceutical deals announced in...
Q1 2024 update: digitalization related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that digitalization accounted for 9 pharmaceutical deals announced in Q1 2024,...